AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Argiro, L Desbarats, M Glorieux, FH Ecarot, B
Citation: L. Argiro et al., MEPE, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone, GENOMICS, 74(3), 2001, pp. 342-351

Authors: Primorac, D Rowe, DW Mottes, M Barisic, I Anticevic, D Mirandola, S Lira, MG Kalajzic, I Kusec, V Glorieux, FH
Citation: D. Primorac et al., Osteogenesis imperfecta at the beginning of bone and joint decade, CROAT MED J, 42(4), 2001, pp. 393-415

Authors: Gong, YQ Slee, RB Fukai, N Rawadi, G Roman-Roman, S Reginato, AM Wang, HW Cundy, T Glorieux, FH Lev, D Zacharin, M Oexle, K Marcelino, J Suwairi, W Heeger, S Sabatakos, G Apte, S Adkins, WN Allgrove, J Arslan-Kirchner, M Batch, JA Beighton, P Black, GCM Boles, RG Boon, LM Borrone, C Brunner, HG Carle, GF Dallapiccola, B De Paepe, A Floege, B Halfhide, ML Hall, B Hennekam, RC Hirose, T Jans, A Juppner, H Kim, CA Keppler-Noreuil, K Kohlschuetter, A LaCombe, D Lambert, M Lemyre, E Letteboer, T Peltonen, L Ramesar, RS Romanengo, M Somer, H Steichen-Gersdorf, E Steinmann, B Sullivan, B Superti-Furga, A Swoboda, W van den Boogaard, MJ Van Hul, V Vikkula, M Votruba, M Zabel, B Garcia, T Baron, R Olsen, BR Warman, ML
Citation: Yq. Gong et al., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development, CELL, 107(4), 2001, pp. 513-523

Authors: Dardenne, O Prud'homme, J Arabian, A Glorieux, FH St-Arnaud, R
Citation: O. Dardenne et al., Targeted inactivation of the 25-hydroxyvitamin D-3-1 alpha-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets, ENDOCRINOL, 142(7), 2001, pp. 3135-3141

Authors: Parfitt, AM Travers, R Rauch, F Glorieux, FH
Citation: Am. Parfitt et al., Structural and cellular changes during bone growth in healthy children, BONE, 27(4), 2000, pp. 487-494

Authors: Rauch, F Travers, R Parfitt, AM Glorieux, FH
Citation: F. Rauch et al., Static and dynamic bone histomorphometry in children with osteogenesis imperfecta, BONE, 26(6), 2000, pp. 581-589

Authors: Rauch, F Lauzier, D Croteau, S Travers, R Glorieux, FH Hamdy, R
Citation: F. Rauch et al., Temporal and spatial expression of bone morphogenetic protein-2,-4, and-7 during distraction osteogenesis in rabbits, BONE, 26(6), 2000, pp. 611-617

Authors: Glorieux, FH Travers, R Taylor, A Bowen, JR Rauch, F Norman, M Parfitt, AM
Citation: Fh. Glorieux et al., Normative data for iliac bone histomorphometry in growing children, BONE, 26(2), 2000, pp. 103-109

Authors: Glorieux, FH Rauch, F Plotkin, H Ward, L Travers, R Roughley, P Lalic, L Glorieux, DF Fassier, F Bishop, NJ
Citation: Fh. Glorieux et al., Type V osteogenesis imperfecta: A new form of brittle bone disease, J BONE MIN, 15(9), 2000, pp. 1650-1658

Authors: Rauch, F Travers, R Norman, ME Taylor, A Parfitt, AM Glorieux, FH
Citation: F. Rauch et al., Deficient bone formation in idiopathic juvenile osteoporosis: A histomorphometric study of cancellous iliac bone, J BONE MIN, 15(5), 2000, pp. 957-963

Authors: Lapillonne, A Picaud, JC Glorieux, FH Salle, BL
Citation: A. Lapillonne et al., Bone turnover assessment in infants, ACT PAEDIAT, 89(7), 2000, pp. 772-774

Authors: Glorieux, FH
Citation: Fh. Glorieux, Bisphosphonate therapy for severe osteogenesis imperfecta, J PED END M, 13, 2000, pp. 989-992

Authors: Plotkin, H Glorieux, FH
Citation: H. Plotkin et Fh. Glorieux, Medical treatment of osteogenesis imperfecta, DRUG DEV R, 49(3), 2000, pp. 141-145

Authors: Rauch, F Schonau, E Glorieux, FH
Citation: F. Rauch et al., Bisphosphonates - pediatric use, MONATS KIND, 148(4), 2000, pp. 334-341

Authors: Plotkin, H Rauch, F Bishop, NJ Montpetit, K Ruck-Gibis, J Travers, R Glorieux, FH
Citation: H. Plotkin et al., Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age, J CLIN END, 85(5), 2000, pp. 1846-1850

Authors: St-Arnaud, R Arabian, A Travers, R Barletta, F Raval-Pandya, M Chapin, K Depovere, J Mathieu, C Christakos, S Demay, MB Glorieux, FH
Citation: R. St-arnaud et al., Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D, ENDOCRINOL, 141(7), 2000, pp. 2658-2666

Authors: Salle, BL Delvin, EE Lapillonne, A Bishop, NJ Glorieux, FH
Citation: Bl. Salle et al., Perinatal metabolism of vitamin D, AM J CLIN N, 71(5), 2000, pp. 1317S-1324S

Authors: Boyde, A Travers, R Glorieux, FH Jones, SJ
Citation: A. Boyde et al., The mineralization density of iliac crest bone from children with osteogenesis imperfecta, CALCIF TIS, 64(3), 1999, pp. 185-190

Authors: Jones, SJ Glorieux, FH Travers, R Boyde, A
Citation: Sj. Jones et al., The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: A survey using backscattered electron imaging, CALCIF TIS, 64(1), 1999, pp. 8-17
Risultati: 1-19 |